ScottDavidSolomonMD
Cardiology • Boston, MAProfessor, Medicine-Brigham & Women's Hospital, Harvard Medical School
Dr. Solomon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# PBB1
Boston, MA 02115Phone+1 617-732-7182Fax+1 857-307-0899
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1989 - 1992- Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Hispanic Community Health Study / Study of Latinos Start of enrollment: 2006 Jan 01
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure Start of enrollment: 2016 Aug 01
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. Start of enrollment: 2021 Mar 20
Publications & Presentations
PubMed
- 8 citationsCharacteristics and outcomes of patients with a history of cancer recruited to heart failure trials.Stephen J H Dobbin, Li Shen, Mark C Petrie, Milton Packer, Scott D Solomon
European Journal of Heart Failure. 2023-04-01 - 548 citationsHow to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) ...Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, Alan G Fraser, Stefan D Anker
European Heart Journal. 2019-10-21 - 1 citationsDuration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.John W Ostrominski, Brian L Claggett, Milton Packer, Marc A Pfeffer, Carolyn S P Lam
Journal of Cardiac Failure. 2023-11-01
Journal Articles
- Mini Focus on Diabetes Original Investigation Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic RiskNora Franceschini, Amil Shah, Calum A MacRae, Sara B Seidelmann, Scott D Solomon, Susan Cheng, ScienceDirect
- Growth Differentiation Factor‐15 Is Not Modified by sacubitril/valsartan and Is an Independent Marker of Risk in Patients with Heart Failure and Reduced Ejection Fract...Milton Packer, Scott D Solomon, Michael R Zile, European Journal of Heart Failure
- Clinical Research Vaccination Trends in Patients with Heart Failure: Insights from Get with the Guidelines–Heart FailureAdam D DeVore, Adrian F Hernandez, Scott D Solomon, Orly Vardeny, Ankeet S Bhatt, Gregg C Fonarow, Robert J Mentz, Clyde W Yancy, Ileana L Pina, ScienceDirect
- Join now to see all
Lectures
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesScientific Sessions 2007, Orlando, Florida, USA
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesEuropean Society of Cardiology, ESC Congress 2012, Munich, Germany
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesEuropean League Against Rheumatism, Annual European Congress of Rheumatology 2008, Paris, France
- Join now to see all
Press Mentions
Estimated Long-Term Benefits of Finerenone in Heart FailureSeptember 27th, 2024- Clinical Trials Observed Cardiovascular Death and Worsening Heart Failure Reduced by FinerenoneSeptember 4th, 2024
- Heart Drug Improved Exercise Tolerance in Clinical Trial of Patients with Hypertrophic Obstructive CardiomyopathySeptember 4th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
